Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Get Credit for Getting Green with NJ’s Sustainable Business Registry

8/9/2015

0 Comments

 
Trenton, NJ - New Jersey offers businesses the opportunity to promote their “green” initiatives for free by signing up for the NJ Sustainable Business Registry.  It’s a no-cost way to promote your business and distinguish yourself from the competition by being socially responsible.

Read More
0 Comments

NJ Lab Equipment Testing Company Welcomes GE Product Line

8/9/2015

1 Comment

 
Bound Brook, NJ - A New Jersey company that specializes in monitoring and maintaining the accuracy of laboratory equipment has expanded its role even further by adding a well known innovator, General Electric, as a provider among its array of high-tech equipment and services. Baseline Service, LLC, headquartered in Bound Brook, NJ, recently announced that it is a distributor for GE's Measurement & Control Division.

Read More
1 Comment

Catalent Biologics announces new advisory board

8/9/2015

0 Comments

 
Somerset, NJ - According to Emily Bader of NJBiz, "Catalent announced it has formed an advisory board to structure the development of its biologics business. The Somerset-based provider of advanced technologies said in a news release that the founding members of its advisory board are Carolyn Bertozzi, Barry Buckland, Michael Buckley, Daniel R. Marshak and Edward R. Robinson.

Read More
0 Comments

Immunomedics Announces Orphan Drug Designation for Veltuzumab for the Treatment of Immune Thrombocytopenia

8/9/2015

1 Comment

 
Morris Plains, NJ - Immunomedics, Inc. today announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) has granted orphan status for the use of veltuzumab, the Company’s humanized anti-CD20 antibody, for the treatment of immune thrombocytopenia (ITP). In a Phase 1 study,1 low-dose veltuzumab, as a single agent, produced an objective response rate of 55 percemt in 38 response-assessable patients with relapsed ITP, including 11 patients (29 percent) who reported a complete response. 

Read More
1 Comment

Drug development firm moving to Jersey City

8/9/2015

0 Comments

 
Jersey City, NJ - According to Eric Strauss of NJBiz, "A North Carolina drug development company is selling off one of its businesses and moving to Jersey City. Scynexis Inc. will relocate from Research Triangle Park effective Aug. 1, it said in a news release, and focus on developing its SCY-078 antifungal drug."

Read More
0 Comments

Stevens receives $250K grant from PSEG Foundation

8/4/2015

1 Comment

 
Hoboken, NJ - According to Andrew Sheldon of NJBiz, "Stevens Institute of Technology has received a $250,000 grant from the PSEG Foundation to be put toward the completion of the university's SURE HOUSE, which is the school's entry into the U.S. Department of Energy's Solar Decathlon competition. The SUstainable and REsilient HOUSE represents the school’s vision of a sustainable and resilient home for the areas at greatest risk during extreme weather.

Read More
1 Comment

Join Innovation New Jersey's LinkedIn Group

8/4/2015

0 Comments

 
Trenton, NJ - The Innovation New Jersey Coalition is a diverse coalition of leading businesses, trade associations and higher education institutions established to strengthen and enhance the culture of innovation in New Jersey.  Join us on LinkedIn to continue to collaborate and innovate: https://www.linkedin.com/groups/Innovation-New-Jersey-8356334/about
0 Comments

Joe Torre Foundation Receives $65,000 Grant From Verizon Wireless And The Verizon Foundation

8/4/2015

0 Comments

 
Trenton, NJ - Officials with Verizon Wireless and the Verizon Foundation recently presented a $65,000 HopeLine grant to the Joe Torre Safe At Home Foundation® at Emerson Middle School in Union City. The grant will be used to support the Foundation’s educational initiative, Margaret’s Place, at Emerson Middle School – in addition to other locations throughout the region. Margaret’s Place offers students a “safe room” in schools to talk with each other and a professional counselor about violence-related issues.

Read More
0 Comments

Task Force to Recommend How to Integrate Engineering into K-12 Curriculum Heads to Gov's Desk

8/4/2015

0 Comments

 
Trenton, NJ - Legislation sponsored by Assemblyman Patrick Diegnan and Assembly colleagues to create a task force charged with recommending how to incorporate engineering into the K-12 science curriculum received final legislative approval last month and now heads to the governor's desk.

Read More
0 Comments

Merck buys Israeli biopharma firm for $95M

8/4/2015

0 Comments

 
Kenilworth, NJ - According to Eric Strauss of NJBiz, "Merck is acquiring an Israeli biopharmaceutical company for $95 million in cash, the drugmaker announced Tuesday. The Kenilworth-based company’s deal for cCAM Biotherapeutics, which is focused on cancer immunotherapies, could potentially include up to $510 million in milestone payments, it said."

Read More
0 Comments

States to Colleges: Prove You’re Worth It According to Pew

8/4/2015

0 Comments

 
Washington D.C. - According to Sophie Quinton of Pew Charitable Trust, "New College of Florida doesn’t offer pre-professional degrees, like nursing or engineering. Students choose the public liberal arts college because they want an intellectual experience. Many take a year off after graduation to pursue research or community service. Yet last fall, New College opened a flashy new career center on its Sarasota campus. It needed to prove to the state that it was helping students find jobs and graduate on time, or risk losing $1.1 million in state aid. “That’s a big deal for us,” David Gulliver, media relations coordinator for New College, said of the money.  

Read More
0 Comments

Wheaton to Commercialize Breakthrough Technology Providing Plastic Components with Pure Glass Interiors

8/4/2015

1 Comment

 
Millville, NJ - According to New Jersey Business magazine, "WHEATON® announced that it will begin offering an innovative, breakthrough technology that allows for the manufacture of plastic exterior components with complete interior coverage of pure glass. The broad range of products envisioned from the application of this technology will provide numerous benefits to its clinical science customers. Attendees of the 2015 AACC Clinical Lab Expo, July 26-30 at the Georgia World Congress Center in Atlanta, are invited to visit WHEATON® at Booth 3615 to learn more about this innovative technology."

Read More
1 Comment

House Delays Action on Patent Reform

8/4/2015

0 Comments

 
Washington D.C. - Opposition to H.R. 9, the Innovation Act, has successfully removed the patent reform legislation from the House's pre-recess schedule. The collective voice of the life sciences community, including BioNJ and BIO, was raised in overwhelming opposition to the current version of the bill, which does not provide adequate reform to the IPR system of patent challenges at the U.S. Patent & Trademark Office (PTO).

Read More
0 Comments

Internet of Medical Things Addresses CyberSecurity Issues Facing Pharmas and Device Developers 

8/4/2015

1 Comment

 
Tinton Falls, NJ - At the Internet of Medical Things speakers from Johnson & Johnson, the FDA, Sage Bionetworks, and WAM Consulting Group presented their perspectives on issues key to developing safeguards for drug development data, patient records, and medical devices. Dr. Suzanne Schwartz, the FDA’s Director for Emergency Preparedness, addressed the agency’s approach to building internal communications and public­ private partnerships to enhance cybersecurity throughout the healthcare system. While it’s not always easy to find a “front door” for collaborating with the FDA, she mentioned National Healthcare & Public Health Critical Infrastructure Protection (http://www.nhisac.org/). 

Read More
1 Comment

Merck Marks 30-Year Milestone in Commitment to Innovation and Care in HIV/AIDS

7/27/2015

0 Comments

 
Kenilworth, NJ - Merck, known as MSD outside the United States and Canada, announced today that the company's commitment to HIV and AIDS, which started with a research and development program initiated in the mid-1980s during the early years of the epidemic, is now entering its fourth decade. To commemorate Merck's 30 years of commitment in this area, the company is launching a new effort, “Positively Committed.” The campaign highlights the company’s contributions, including the development of innovative therapies to address the unmet medical needs of people infected with HIV-1.

Read More
0 Comments
<<Previous
Forward>>
    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Health Care
    Healthcare
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608
732-729-9619